{"name":"Finch Research and Development LLC.","slug":"finch-research-and-development-llc","ticker":"","exchange":"","domain":"","description":"Finch Research and Development LLC is a biotechnology company focused on developing innovative therapies. The company's primary focus has been on the development of CP101, which was discontinued. Finch continues to explore new opportunities in the therapeutic space.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNdFdVdmZBZlpZVWpCY0FtS3RUdW5sOF9MME1tWnYtWEthN2cxb2E3THJvSzhmZ010OHlndl9PampVN0lMd05yY3pTbGJNTkY2YVpNYUV4cmJINkp2MFUyUjZLeThXdnRyRUN5X3ZNY2FxR1dRTGxMYWlrUnNnZER0ZVlVdTkyNFNNeGVfOVJ6VV8xZ3Nqb285Ymk3MmhtVldkSm40TEpqZE56YkdV?oc=5","date":"2026-03-23","type":"pipeline","source":"WhatNow","summary":"Boston Biotech Company Files for Chapter 11 Amid Financial Reorganization - WhatNow","headline":"Boston Biotech Company Files for Chapter 11 Amid Financial Reorganization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQZVkzVGVmN1hEYURVRnppWFRwVkZzeGwzOHJNWlpsX0lEbDhudkYwWkpnSW1yRUxwcHFGZEJ5NXNRV19rb196ajhwV1JzR3MzTjM3QVlfUUlTRWJRMjBTT1RERXZmQ3NFVDIyUF9uRG9VSkI2OGRXTHg5MDVOX3JtUVRSVTl1SVd4R0tUUlBBSkVaQ2JHX0ttMWxOU0zSAaIBQVVfeXFMT1dmZDFnMlJPRkI3aDZOWGFqMmhVeGxVcU9LbjdsLXZ4TmdXNTU0SGNVcEFFWVh0MlREQ050dDlhUkxuTmJFcjdTOFJxT3RBWF93WExmeXg1cmxrNHNiVnRGbTY4NzhBMVBiQ1lXUk1xYl82SGdRaUloZHpkZlk0a3VNUlFMRzJzbzhRWHQ4TFAtNTUtamRyZ0M1a3JlSVJFUUVR?oc=5","date":"2026-03-23","type":"pipeline","source":"The National Law Review","summary":"Weekly Bankruptcy Alert March 23, 2026 (For the Week Ending March 22, 2026) - The National Law Review","headline":"Weekly Bankruptcy Alert March 23, 2026 (For the Week Ending March 22, 2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQM1h0MGRaaTUzSDlsUlJvLXZIM3RjRGhKdzNoQmRRZV9LMktmZjlCcEJlVFVtaThHR1B2cFpodDNBZmVyYmEzenp5UEt0cmxBVFg2dWNOMUhEVXdkYjFsMDNxblpoc1JkdTk3c2FTLUxwdXhvVlpULU1zX28yUWhCeVk1R2RYM1lBdkM1VzB5LVpQcnZ3MzVHRE45RTlLMVdOWVlmcEhINVlQXzQ?oc=5","date":"2025-02-21","type":"pipeline","source":"Northwestern University","summary":"Microbiota Transplant Shows Promise for Colon Infections - Northwestern University","headline":"Microbiota Transplant Shows Promise for Colon Infections","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQb2lKbG0xaENwZkFyR0o5VXNIZ0U0QVJGNkRXRUlYbGVXNTBCWGZ5b1hjXy01dUhiREpNbWU0ZkkwRjlTX0g0N2hfeHZ5ZndEOXRXajZUUU95YTUtWUhuNGNuVGpORXplOF9kWmYzYy14TzJQLXcwTnZtLWY3RGRCLUhoZXd1TXF1cS03X2RMeVNCUXZrYW11UTBucmV3bWJROW4xMEFJanVfSGFhVFRXZ3RnVjNjM085NUlFMlY3cUh4OHl4WGJ3aA?oc=5","date":"2023-01-24","type":"trial","source":"Fierce Biotech","summary":"Frosty funding forecast forces Finch to stop phase 3 trial, lay off 95% of staff and seek buyers for assets - Fierce Biotech","headline":"Frosty funding forecast forces Finch to stop phase 3 trial, lay off 95% of staff and seek buyers for assets","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQNE9VYW5HTC15MUhwQ01ZRGx1Nm5lSXYxZE5YVkFfSm9SRFJ1S2txWVVXc1FJTktCeWJUX0RZb3htaFd1bnp1RlBPWXdzVUg1azBTbVBmZGV0ZTgwaVlnb3Z5b3ZCcTVzbWhQWVBCZEtJckJKUk8yRktSMEk4QnptMVk2eTRMWl82ZmQtQmhmWkZaMDRob2xVcE9UY2NuMTBFRWxFbw?oc=5","date":"2022-08-26","type":"pipeline","source":"Fierce Biotech","summary":"Takeda returns 2 inflammatory bowel prospects back to Finch's nest - Fierce Biotech","headline":"Takeda returns 2 inflammatory bowel prospects back to Finch's nest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBNdkZmMXFWYVppUUFOS0doMkVQLUVTcGY5VkdnOEV4ekdDbDQ5Xzk0el80S2lNQXN5Z09LS2dlalRCUW14ZGZvOWFZanZqMXZaMjVJX0l1RVRLdw?oc=5","date":"2021-03-19","type":"pipeline","source":"MarketBeat","summary":"Finch Therapeutics Group (FNCH) Stock Price, News & Analysis - MarketBeat","headline":"Finch Therapeutics Group (FNCH) Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}